{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:49:53Z","timestamp":1791607793242,"version":"4.3.4"},"reference-count":127,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.bone.2007.03.017","type":"journal-article","created":{"date-parts":[[2007,4,7]],"date-time":"2007-04-07T11:17:16Z","timestamp":1175944636000},"page":"1434-1446","source":"Crossref","is-referenced-by-count":623,"title":["Molecular and cellular mechanisms of the anabolic effect of intermittent PTH"],"prefix":"10.1016","volume":"40","author":[{"given":"Robert L.","family":"Jilka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2007.03.017_bib1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bone.2007.03.017_bib2","series-title":"Principals of bone biology","first-page":"1305","article-title":"Parathyroid hormone","author":"Hodsman","year":"2002"},{"key":"10.1016\/j.bone.2007.03.017_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S8756-3282(03)00202-3","article-title":"Anabolic and catabolic bone effects of human parathyroid hormone (1\u201334) are predicted by duration of hormone exposure","volume":"33","author":"Frolik","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib4","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib5","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1210\/jc.77.6.1535","article-title":"Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1\u201334): kinetics and biochemical response in estrogenized osteoporotic patients","volume":"77","author":"Lindsay","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2007.03.017_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jc.2002-021122","article-title":"Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis","volume":"88","author":"Horwitz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2007.03.017_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2007.03.017_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1359\/jbmr.060314","article-title":"Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis","volume":"21","author":"Ma","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib9","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1359\/JBMR.050309","article-title":"Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters","volume":"20","author":"Arlot","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1359\/jbmr.2002.17.5.808","article-title":"Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice","volume":"17","author":"Iida-Klein","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib11","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/en.138.11.4607","article-title":"The effects of programmed administration of human parathyroid hormone fragment (1\u201334) on bone histomorphometry and serum chemistry in rats","volume":"138","author":"Dobnig","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib12","doi-asserted-by":"crossref","first-page":"50259","DOI":"10.1074\/jbc.M307444200","article-title":"Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts: a putative explanation for why intermittent administration is needed for bone anabolism","volume":"278","author":"Bellido","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2007.03.017_bib14","unstructured":"Parfitt AM. Bone-forming cells in clinical conditions. In: Hall BK, editor. Bone. Volume 1. The Osteoblast and Osteocyte. Boca Raton, FL: Telford Press and CRC Press; 1990. p. 351\u2013429."},{"key":"10.1016\/j.bone.2007.03.017_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.060107","article-title":"Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss","volume":"21","author":"Aguirre","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib16","series-title":"Principles of bone biology","first-page":"151","article-title":"Apoptosis in bone cells","author":"Boyce","year":"2002"},{"key":"10.1016\/j.bone.2007.03.017_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/er.21.2.115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bone.2007.03.017_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1359\/JBMR.041114","article-title":"Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling","volume":"20","author":"Riggs","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib19","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1210\/jc.84.5.1562","article-title":"On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism","volume":"84","author":"Dempster","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2007.03.017_bib20","series-title":"Principles of bone biology","first-page":"59","article-title":"Mesenchymal stem cells and osteoblast differentiation","author":"Aubin","year":"2002"},{"key":"10.1016\/j.bone.2007.03.017_bib21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI200419900","article-title":"PPAR\u03b3 insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors","volume":"113","author":"Akune","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2007.03.017_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1090985","article-title":"Regulation of bone mass in mice by the lipoxygenase gene Alox15","volume":"303","author":"Klein","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bone.2007.03.017_bib23","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/en.2004-0735","article-title":"Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation","volume":"146","author":"Ali","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib24","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.02480","article-title":"Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors","volume":"133","author":"Rodda","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.bone.2007.03.017_bib25","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2007.03.017_bib26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.bone.2007.03.017_bib27","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib28","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.1074\/jbc.M609509200","article-title":"LRP5 Mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST","volume":"281","author":"Semenov","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib29","series-title":"When cells die","first-page":"411","article-title":"Regulation of apoptosis by cellular interactions with the extracellular matrix","author":"Tidball","year":"1998"},{"key":"10.1016\/j.bone.2007.03.017_bib30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1359\/jbmr.1998.13.5.793","article-title":"Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines","volume":"13","author":"Jilka","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2007.03.017_bib32","first-page":"S94","article-title":"Decreased defense against reactive oxygen species: a common pathogenetic mechanism of the effects of aging and estrogen deficiency on bone","volume":"20","author":"Manolagas","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1359\/jbmr.2003.18.6.960","article-title":"High bone mass in mice expressing a mutant LRP5 gene","volume":"18","author":"Babij","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib34","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1359\/jbmr.1997.12.11.1864","article-title":"Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone","volume":"12","author":"Parfitt","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1359\/jbmr.1997.12.4.498","article-title":"Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss","volume":"12","author":"Han","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.0909-8836.1999.eos107406.x","article-title":"Apoptosis in murine calvarial bone and suture development","volume":"107","author":"Rice","year":"1999","journal-title":"Eur J Oral Sci"},{"key":"10.1016\/j.bone.2007.03.017_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0736-0266(02)00097-9","article-title":"Rapid new bone tissue remodeling during distraction osteogenesis is associated with apoptosis","volume":"21","author":"Li","year":"2003","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bone.2007.03.017_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.1.06057","article-title":"Parathyroid hormone: past and present","volume":"187","author":"Potts","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bone.2007.03.017_bib39","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1074\/jbc.M513380200","article-title":"Distinct b-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1\/2 activation","volume":"281","author":"Gesty-Palmer","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2004.11.069","article-title":"Parathyroid hormone and parathyroid hormone-related peptide, and their receptors","volume":"328","author":"Gensure","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2007.03.017_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02529728","article-title":"Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1\u201331)NH2 (Ostabolin)","volume":"58","author":"Whitfield","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2007.03.017_bib42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1359\/jbmr.1997.12.3.384","article-title":"An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats","volume":"12","author":"Armento-Villareal","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib43","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1210\/en.2004-1282","article-title":"Bone response to intermittent parathyroid hormone is altered in mice null for b-arrestin2","volume":"146","author":"Ferrari","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.bone.2006.12.003","article-title":"CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment","volume":"40","author":"Liu","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1359\/jbmr.060915","article-title":"Cotreatment of parathyroid hormone with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice","volume":"22","author":"Samadfam","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/me.2002-0225","article-title":"PTH bone anabolic action requires Cbfa1\/Runx2-dependent signaling","volume":"17","author":"Krishnan","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bone.2007.03.017_bib47","doi-asserted-by":"crossref","first-page":"16347","DOI":"10.1074\/jbc.M603439200","article-title":"Cyclin D1-Cdk4 induce Runx2 ubiquitination and degradation","volume":"281","author":"Shen","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1083\/jcb.200409187","article-title":"Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma","volume":"167","author":"Thomas","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2007.03.017_bib49","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1074\/jbc.M409846200","article-title":"Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase","volume":"280","author":"Qin","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib50","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.bone.2006.06.010","article-title":"Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells","volume":"39","author":"Rickard","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib51","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/en.142.9.4047","article-title":"Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib52","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1074\/jbc.M110433200","article-title":"Internalization determinants of the parathyroid hormone receptor differentially regulate b-arrestin\/receptor association","volume":"277","author":"Vilardaga","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S8756-3282(00)00309-4","article-title":"In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1\u201334) fragment","volume":"27","author":"Stanislaus","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S8756-3282(96)00350-X","article-title":"Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro","volume":"20","author":"Onyia","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib55","first-page":"S412","article-title":"Evidence that the cellular mechanisms responsible for the anabolic effects of intermittent PTH are different in murine cancellous and periosteal bone","volume":"20","author":"Ali","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1359\/jbmr.070104","article-title":"Effects of a one-month treatment with parathyroid hormone (1\u201334) on bone formation on cancellous, endocortical and periosteal surfaces of the human ilium","volume":"22","author":"Lindsay","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/002215549804600306","article-title":"TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement","volume":"46","author":"Labat-Moleur","year":"1998","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.bone.2007.03.017_bib58","doi-asserted-by":"crossref","first-page":"19374","DOI":"10.1074\/jbc.M108913200","article-title":"Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells","volume":"277","author":"Chen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib59","first-page":"639","article-title":"The role of the cyclin-dependent kinase inhibitor p21 in apoptosis","volume":"1","author":"Gartel","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bone.2007.03.017_bib60","doi-asserted-by":"crossref","first-page":"21137","DOI":"10.1074\/jbc.273.33.21137","article-title":"Transcriptional Activation of the p21WAF1, CIP1, SDI1 gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells","volume":"273","author":"Bellido","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1172\/JCI11296","article-title":"Activated parathyroid hormone\/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone","volume":"107","author":"Calvi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2007.03.017_bib62","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/en.136.8.3632","article-title":"Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells","volume":"136","author":"Dobnig","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib63","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1359\/jbmr.1999.14.10.1691","article-title":"Intermittent administration of human parathyroid hormone(1\u201334) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice","volume":"14","author":"Sakai","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib64","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1210\/en.2004-0770","article-title":"The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone","volume":"146","author":"Knopp","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/8756-3282(95)00332-2","article-title":"In vivo, human parathyroid hormone fragment (hPTH 1\u201334) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats","volume":"17","author":"Onyia","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib66","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/JBMR.050106","article-title":"PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest","volume":"20","author":"Datta","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1359\/jbmr.1999.14.1.21","article-title":"Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I","volume":"14","author":"Kostenuik","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib68","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bone.2005.02.015","article-title":"Anabolic actions of PTH (1\u201334): use of a novel tissue engineering model to investigate temporal effects on bone","volume":"36","author":"Pettway","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib69","doi-asserted-by":"crossref","first-page":"32204","DOI":"10.1074\/jbc.M101084200","article-title":"Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the ras\/mitogen-activated protein kinase signaling pathway","volume":"276","author":"Miao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib70","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119491","article-title":"Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells","volume":"99","author":"Ishizuya","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2007.03.017_bib71","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00425877","article-title":"Time-dependent effects of parathyroid hormone and prostaglandin E2 on DNA synthesis by periosteal cells from embryonic chick calvaria","volume":"55","author":"Scutt","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2007.03.017_bib72","doi-asserted-by":"crossref","first-page":"7586","DOI":"10.1074\/jbc.M007400200","article-title":"Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent","volume":"276","author":"Swarthout","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib73","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1210\/endo-118-6-2445","article-title":"Parathyroid hormone stimulates the proliferation of cells derived from human bone","volume":"118","author":"MacDonald","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib74","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bone.2005.06.013","article-title":"Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1\u201334) on chondrogenesis in a model of experimental fracture healing","volume":"37","author":"Nakazawa","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib75","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1210\/en.142.11.4900","article-title":"PTHrP inhibits adipocyte differentiation by down-regulating PPAR\u03b3 activity via a MAPK-dependent pathway","volume":"142","author":"Chan","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib76","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1359\/JBMR.040112","article-title":"Teriparatide [PTH(1\u201334)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity","volume":"19","author":"Sato","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib77","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1210\/en.136.8.3624","article-title":"Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1\u201334), and bovine PTH-(1\u201334)","volume":"136","author":"Leaffer","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib78","series-title":"Skeletal growth factors","first-page":"101","article-title":"Insulin-like growth factors and the skeleton","author":"Conover","year":"2000"},{"key":"10.1016\/j.bone.2007.03.017_bib79","series-title":"The parathyroids. Basic and clinical concepts","first-page":"411","article-title":"Cytokines in primary hyperparathyroidism","author":"Nakchbandi","year":"2001"},{"key":"10.1016\/j.bone.2007.03.017_bib80","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1359\/jbmr.1999.14.5.776","article-title":"Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells","volume":"14","author":"Hurley","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib81","doi-asserted-by":"crossref","first-page":"19723","DOI":"10.1074\/jbc.M212226200","article-title":"Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics","volume":"278","author":"Qin","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib82","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1097-4644(19980901)70:3<391::AID-JCB12>3.0.CO;2-O","article-title":"Intermittent administration of parathyroid hormone (1\u201334) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone","volume":"70","author":"McClelland","year":"1998","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2007.03.017_bib83","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1210\/en.141.12.4533","article-title":"ADAMTS-1: a cellular disintegrin and metalloprotease with thrombospondin motifs is a target for parathyroid hormone in bone","volume":"141","author":"Miles","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib84","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1210\/en.2003-0350","article-title":"Parallel phosphatidylinositol-3 kinase and p42\/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells","volume":"144","author":"Grey","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib85","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/8756-3282(94)00051-4","article-title":"Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats","volume":"16","author":"Watson","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib86","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcb.10490","article-title":"Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone","volume":"89","author":"Locklin","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2007.03.017_bib87","first-page":"S322","article-title":"Gene expression patterns in response to daily injections of PTH to mice: evidence for priming by the initial dose","volume":"21","author":"Chen","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib88","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","article-title":"Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone","volume":"17","author":"Bikle","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib89","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1210\/en.142.10.4349","article-title":"Evidence that anabolic effects of PTH on bone require IGF-I in growing mice","volume":"142","author":"Miyakoshi","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib90","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1210\/en.2004-1511","article-title":"Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice","volume":"146","author":"Yamaguchi","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib91","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1677\/joe.1.06657","article-title":"The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone","volume":"189","author":"Yakar","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bone.2007.03.017_bib92","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbrc.2006.01.044","article-title":"Impaired bone anabolic response to parathyroid hormone in Fgf2\u2212\/\u2212 and Fgf2+\/\u2212 mice","volume":"341","author":"Hurley","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2007.03.017_bib93","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/jbmr.2003.18.12.2105","article-title":"Both hPTH(1\u201334) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture","volume":"18","author":"Lane","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib94","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib95","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/jbmr.5650101213","article-title":"PTH\/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats","volume":"10","author":"Fermor","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib96","doi-asserted-by":"crossref","first-page":"41342","DOI":"10.1074\/jbc.M502168200","article-title":"Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by b-catenin-dependent and-independent signaling cascades involving Src\/ERK and phosphatidylinositol 3-kinase\/AKT","volume":"280","author":"Almeida","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib97","first-page":"S114","article-title":"Selective involvement of WNT signaling pathway in bone anabolic action of parathyroid hormone","volume":"21","author":"Kharode","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib98","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M601000200","article-title":"The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment","volume":"281","author":"Sawakami","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2007.03.017_bib99","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1359\/jbmr.061118","article-title":"PTH stimulates bone formation in mice deficient in Lrp5","volume":"22","author":"Iwaniec","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib100","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1359\/jbmr.2003.18.12.2116","article-title":"Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment","volume":"18","author":"Kim","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib101","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1152\/japplphysiol.01622.2005","article-title":"Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone","volume":"101","author":"Turner","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.bone.2007.03.017_bib102","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S8756-3282(03)00057-7","article-title":"Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice","volume":"32","author":"Zhou","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib103","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1359\/jbmr.1999.14.3.439","article-title":"Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone","volume":"14","author":"Ma","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib104","first-page":"S72","article-title":"Mechanical loading reduces osteocyte expression of sclerostin protein","volume":"21","author":"Robling","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib105","first-page":"S4","article-title":"Activation of PTH receptor 1 specifically in osteocytes suppresses Sost expression and increases bone mass in transgenic mice","volume":"20","author":"O'Brien","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib106","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","article-title":"Osteoclast-derived activity in the coupling of bone formation to resorption","volume":"11","author":"Martin","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.bone.2007.03.017_bib107","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2007.03.017_bib108","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2007.03.017_bib109","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","article-title":"Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate","volume":"19","author":"Ettinger","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","article-title":"The anabolic effect of human PTH (1\u201334) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate\u2014is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system","volume":"16","author":"Delmas","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib111","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/en.132.2.823","article-title":"Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats","volume":"132","author":"Wronski","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib112","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.1998.13.6.1051","article-title":"Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women","volume":"13","author":"Cosman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib113","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1056\/NEJMoa050157","article-title":"Daily and cyclic parathyroid hormone in women receiving alendronate","volume":"353","author":"Cosman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2007.03.017_bib114","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/en.2002-221061","article-title":"New bone formation with teriparatide [human parathyroid hormone-(1\u201334)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats","volume":"144","author":"Ma","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bone.2006.09.010","article-title":"Effects of cyclic vs. daily treatment with human parathyroid hormone (1\u201334) on murine bone structure and cellular activity","volume":"40","author":"Iida-Klein","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib116","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jbmr.5650100106","article-title":"Expression and secretion of parathyroid hormone-related protein by human bone-derived cells in vitro: effects of glucocorticoids","volume":"10","author":"Walsh","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib117","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1359\/jbmr.2005.20.8.1454","article-title":"Stretch-induced PTH-related protein gene expression in osteoblasts","volume":"20","author":"Chen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib118","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1210\/en.2003-1695","article-title":"Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib119","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1172\/JCI24918","article-title":"Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1\u201334","volume":"115","author":"Miao","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2007.03.017_bib120","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1172\/JCI26239","article-title":"Osteoblast-derived PTHrP is a physiological regulator of bone formation","volume":"115","author":"Martin","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2007.03.017_bib121","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI3914","article-title":"Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis","volume":"102","author":"Lane","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2007.03.017_bib122","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bone.2006.01.142","article-title":"The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment","volume":"39","author":"Oxlund","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2007.03.017_bib123","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2007.03.017_bib124","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1359\/jbmr.2003.18.1.18","article-title":"The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis","volume":"18","author":"Marcus","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1011513223894","article-title":"Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis","volume":"2","author":"Justesen","year":"2001","journal-title":"Biogerontology"},{"key":"10.1016\/j.bone.2007.03.017_bib126","first-page":"S36","article-title":"The pathogenesis of age-related bone loss in mice involves increased production of PPAR\u03b3-activating oxidized lipids derived from the lipoxygenase Alox15","volume":"20","author":"Jilka","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2007.03.017_bib127","first-page":"S26","article-title":"Reactive oxygen species antagonize the skeletal effects of Wnt\/b-catenin in vitro and aging mice by diverting b-catenin to FOXO-mediated transcription","volume":"21","author":"Almeida","year":"2006","journal-title":"J Bone Miner Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328207001731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328207001731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T07:14:07Z","timestamp":1707808447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328207001731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":127,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S8756328207001731"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2007.03.017","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}